New Anti-VEGF Agents Extend Dosing Intervals in Wet AMD

New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans.
Medscape Medical News